29 March - 2 April 2021
The Festival of Biologics USA is the meeting place for the life science community to bridge the gap between academia and industry.
With three events in one, the Festival encourages conversation across the entire industry so you can inspire change, champion innovation, and address complex challenges that the biologics industry is facing.
This year, we are launching the Festival of Biologics Europe virtually. We expect over hundreds of attendees logging in from around the globe to hear the latest cutting-edge research in antibodies, immunotherapy and biosimilars.
Live interviews with leading minds in the industry. Expertly led by some of the best interviewers in the business and designed to elicit unique insights.
This is where it gets really interactive. Join a virtual roundtable on a topic of your choice, then virtually meet, discuss and network with operators facing the same issues.
Original presentations from the most informed Industry experts. Genuine leaders that you can learn from and take away tangible insights for your business.
We have curated panels of 4-5 industry experts to debate some of your burning questions. You’ll be able to watch them live and pose questions directly the panelists.
Virtual meetings have become the new norm. You can select those you’d like to meet from the list of registered participants. We’ll then set up and host a virtual meeting with you and your selected participants.
All Year Round Our new platform is not only giving you access to a one-off event but an opportunity to take part, or even host Webinars and virtual meetings throughout the year. Leveraging our vast global community and enable you to connect all year round.
The Festival of Biologics 2021 offers outstanding opportunities for solutions providers, from senior sponsorship to a range of exhibition booths on a large floor plan.
There are two parts to the Festival of Biologics: three conferences covering Antibodies, Immunotherapy, Biosimilars and an exhibition featuring solutions for pharma and biotech.